Regeneron Ventures
55 Old Field Point Road, Greenwich, CT, 06830, United States
Overview
Health care venture capital fund.
Founded
2024
Deals · 12mo
9
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Infinimmune | Aug 2026Led | $75 MSeries A | |
City Therapeutics | Jun 2026Participated | $100 MSeries B | |
Coultreon Biopharma | Apr 2026Participated | $125 MSeries A | |
Neomorph | Apr 2026Participated | $100 MSeries B | |
Atavistik Bio | Mar 2026Participated | $40 MSeries B | |
Think Bioscience | Jan 2026Led | $55 MSeries A | |
Atavistik Bio | Dec 2025Participated | $120 MSeries B | |
Triana Biomedicines | Dec 2025Participated | $120 MSeries B | |
Iambic Therapeutics | Nov 2025Participated | $100 MOther Equity | |
Strand Therapeutics | Aug 2025Participated | $153 MSeries B | |
Actio Biosciences | Jun 2025Led | $66 MSeries B | |
Normunity | Jan 2025Participated | $75 MSeries B | |
Infinimmune | Aug 2026Led | $75 MSeries A | |
City Therapeutics | Jun 2026Participated | $100 MSeries B | |
Coultreon Biopharma | Apr 2026Participated | $125 MSeries A | |
Neomorph | Apr 2026Participated | $100 MSeries B | |
Atavistik Bio | Mar 2026Participated | $40 MSeries B | |
Think Bioscience | Jan 2026Led | $55 MSeries A | |
Atavistik Bio | Dec 2025Participated | $120 MSeries B | |
Triana Biomedicines | Dec 2025Participated | $120 MSeries B | |
Iambic Therapeutics | Nov 2025Participated | $100 MOther Equity | |
Strand Therapeutics | Aug 2025Participated | $153 MSeries B | |
Actio Biosciences | Jun 2025Led | $66 MSeries B | |
Normunity | Jan 2025Participated | $75 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 3 | 3 |
| Series B | 2 | 7 |
| Series C+ | 0 | 1 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 2 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 2 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 2 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 17 |
| AI & Machine Learning | 2 |
| Enterprise Software | 1 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 1 |
| $50M-$100M | 6 |
| $100M-$250M | 9 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 16 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Invus | 4 |
| Alexandria Venture Investments | 3 |
| ARCH Venture Partners | 3 |
| RA Capital Management | 3 |
| Rock Springs Capital | 3 |
| Samsara BioCapital | 3 |
| YK Bioventures | 3 |
| Amgen Ventures | 2 |
| AN Ventures | 2 |
| Ascenta Capital | 2 |
| Canaan Partners | 2 |
| Deerfield Management | 2 |
| Everbright Biofund | 2 |
| Fidelity Management & Research Company | 2 |
| Finchley Healthcare Ventures | 2 |
| Lightspeed Venture Partners | 2 |
| Longwood Fund | 2 |
| Luma Group | 2 |
| Lux Capital | 2 |
| Nextech Invest | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 29% |
| Participating | 12 | 71% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 5 | 100% |